4//SEC Filing
Kelly John Alexander 4
Accession 0001628280-25-048858
CIK 0001357874other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:15 PM ET
Size
9.3 KB
Accession
0001628280-25-048858
Insider Transaction Report
Form 4
Kelly John Alexander
Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-11-02−3,605→ 0 total→ Common Stock (3,605 underlying) - Sale
Common Stock
2025-11-03$6.49/sh−1,303$8,456→ 77,298 total - Exercise/Conversion
Common Stock
2025-11-02+3,605→ 78,601 total
Footnotes (5)
- [F1]Represents the vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2025.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]Includes 1,511 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan at a price of $4.17
- [F4]The sales were effected pursuant to a Rule 10b5-1 plan adopted on January 17, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- [F5]On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on November 2, 2025.
Documents
Issuer
PRECISION BIOSCIENCES INC
CIK 0001357874
Entity typeother
Related Parties
1- filerCIK 0001590030
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 4:15 PM ET
- Size
- 9.3 KB